Clarivate Analytics Deals and Portfolio Review: State of the Industry 2017

Exclusive webinar presentation

  • Date: Tuesday, February 6, 2018
  • Time: 8 am PST / 11am EST (NA) / 4pm BST / 5pm CEST (Europe)

Look back on the industry and dealmaking trends of 2017 and be prepared for what is to come in 2018. Our experts break down the year and provide insight into the industry’s transactions and developments.

Our webinar presentation includes:


○  Overview of dealmaking activity throughout 2017, as captured by Cortellis data tools.
  Deal dollars and volumes by transaction type, therapeutic area and development stage
○  Examination of long term trends versus current developments.


○  2017 Year in Review. A summary of key trends and metrics for innovative pharma and what to watch out for in 2018.
○  Deal-making in the Spotlight. Perspectives on the value of M&A.


Laura Vitez

Laura Vitez has over 25 years of experience in the life sciences industry. She has held lead or advisory roles at multiple small biotechs, a mid-sized pharma company, and two consulting firms, bringing in over $2 billion deal dollars. She holds an MS in biochemistry and a BA in mathematics and chemistry.

Jamie Munro

Jamie Munro leads the Portfolio & Licensing practice at Clarivate Analytics including heading up CMR International, the R&D benchmarking service. Dr Munro has significant life science experience including over 15 years large pharma experience as well as a PhD in Finance.